Toni Mitchell

Single oral doses of netazepide ( <scp>YF</scp> 476), a gastrin receptor antagonist, cause dose‐dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects

Malcolm Boyce, Olivier David, Kate Darwin et al. · Alimentary Pharmacology & Therapeutics · 2012 · 30 citations · Full text

Antiviral Activity, Safety, and Pharmacokinetics of AL-794, a Novel Oral Influenza Endonuclease Inhibitor: Results of an Influenza Human Challenge Study

Jeysen Yogaratnam, Jennifer Rito, Thomas N. Kakuda et al. · The Journal of Infectious Diseases · 2018 · 23 citations · Full text

Using outcome measures in child protection work

Rick Hood, Sue Lansley, Toni Mitchell et al. · Child & Family Social Work · 2020 · 12 citations

Family Medicine, Child Welfare, Social Work Policy +24

Phase I Study on Safety and Pharmacokinetics of a Novel Influenza Endonuclease Inhibitor, AL-794 (JNJ-64155806), following Single- and Multiple-Ascending doses in Healthy Adults

Thomas N. Kakuda, Jeysen Yogaratnam, Jennifer Rito et al. · Antiviral Therapy · 2017 · 11 citations

Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity

Malcolm Boyce, Frans van den Berg, Toni Mitchell et al. · European Journal of Clinical Pharmacology · 2016 · 10 citations